| Holding | Weight on entry |
|---|---|
| Roivant Sciences Ltd. | 0.21% |
| Holding | Weight on exit |
|---|---|
| Insulet Corporation | 0.12% |
| Sonic Healthcare Limited | 0.08% |
| Cochlear Limited | 0.07% |
Holdings compared (excluding cash instruments): 112 → 110.
| Holding | from | to |
|---|---|---|
| Eli Lilly and Company | 11.56% | 10.88% |
| Roche Holding Ltd | 3.94% | 3.68% |
| Holding | 5 Aug | 31 Aug |
|---|---|---|
| Eli Lilly and Company | 11.55% | 10.88% |
| Johnson & Johnson | 7.47% | 7.65% |
| AbbVie Inc. | 5.20% | 5.39% |
| Merck & Co. Inc. | 3.82% | 4.34% |
| UnitedHealth Group Incorporated | 4.43% | 4.22% |
| Roche Holding Ltd | 3.81% | 3.53% |
| Novartis AG | 3.42% | 3.46% |
| AstraZeneca PLC | 2.90% | 2.87% |
| Amgen Inc. | 2.63% | 2.77% |
| Thermo Fisher Scientific Inc. | 2.61% | 2.61% |
Combined top-10 weight: 47.8% → 47.7%.
Bars scaled to the change: orange = up, grey = down. Basket percentages at the two snapshots.
| Country | 5 Aug | 31 Aug |
|---|---|---|
| United States | 72.9% | 73.4% |
| Switzerland | 9.7% | 9.3% |
| United Kingdom | 4.9% | 4.7% |
The three countries that moved the most between the two snapshots.
+3.7% in USD (NAV 69.8 → 72.38, 31 Jul → 31 Aug). Accumulating fund: no distributions.
664 mln $ → 708 mln $ (issuer’s daily series).
| TER | 0.30% — unchanged |
| Transaction costs (KID) | 0.00% — unchanged |
| Index, name, policy | no change in the period |